The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / November / Lipid Control of Light Sensitivity
Research & Innovations Latest News

Lipid Control of Light Sensitivity

Researchers reveal how PIP2 tunes rod photoreceptor signaling

11/4/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll
Objective:

To investigate how phosphatidylinositol-4,5-bisphosphate (PIP2) inhibits the rod photoreceptor channel CNGA1 and to identify the structural basis of this effect.

Approach:
  • Channel reconstitution and functional assays: Researchers purified human CNGA1 and reconstituted it in liposomes and lipid nanodiscs with controlled lipid compositions, then measured channel activity.
  • Structural and mutational analysis: They used single-channel recordings, cryo-electron microscopy, structural modeling, and mutations at candidate PIP2-interaction sites.
Key Findings:
  • Increasing PIP2 reduced CNGA1 activity and its apparent sensitivity to cGMP.
  • At 200 µM cGMP, 0.2% PIP2 reduced channel open probability by about 40%; 1% PIP2 reduced it by more than 90%. PIP2 did not change unitary conductance.
  • With PIP2 present, cryo-EM showed closed and intermediate channel conformations, but not the fully open conformation, even with saturating cGMP.
  • The proposed PIP2-binding pocket lies between neighboring subunits and involves the voltage-sensing, pore, and C-linker regions. Mutations at Arg407 and especially Lys445 reduced or abolished PIP2-mediated inhibition.
Interpretation:

The authors propose that PIP2 inhibits CNGA1 by obstructing C-linker movement needed for pore opening. They suggest that changes in PIP2 levels could influence rod responses by raising the threshold for channel opening.

Limitations:
  • Experiments used homomeric CNGA1 channels rather than the native CNGA1/CNGB1 heterotetramer found in rods.
Conclusion:

The study identifies a structural mechanism for PIP2-mediated inhibition of CNGA1 and a potential allosteric target for future channel-modulating compounds; such compounds were not tested in this study.

Sources:
  • Article context provided

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: